Tag: IBD-

Antibody response in IBD patients, including those receiving biologic therapy at the time of vaccination, similar to that of controls without IBD

Correlation of migraine or severe headache with IBD remains significant overall after adjustment for all covariates

Risk reduced for both ulcerative colitis, Crohn disease; linear dose response seen across increasing quartiles of greenspace

Adding smoke exposure improves the current risk stratification for colorectal neoplasia surveillance strategies

IBD associated with increased prevalence of being prescribed medication and having received acute care services

Receipt of PCV13 alone or in combination with PPSV23 predicts fivefold reduced risk for SPD compared with no vaccination

For every population in BioMe biobank, combining risk scores from distinct ancestral populations improved risk prediction for IBD

Association greater for Crohn disease versus ulcerative colitis

Genetic signature tied to doubled risk for developing potentially fatal blood clots in one in seven IBD patients

However, there is still a gap in life expectancy, health-adjusted life expectancy between those with and without inflammatory bowel disease